Notice Special Procurement Amendment No. 1 OHA Newborn Screening

The Oregon Department of Administrative Services (DAS) is conducting a special procurement on behalf of the Oregon Health Authority (OHA) Public Health Division for the Newborn Screening Program. The procurement involves an amendment to an existing contract with Revvity (formerly PerkinElmer) for the lease of tandem mass spectrometer instruments, purchase of newborn screening test kits, and maintenance of Specimen Gate software. The primary objective is to extend the current contract for five years through September 30, 2028, with a focus on continuing critical newborn screening services for Oregon and several partner states including Alaska, Hawaii, Idaho, Nevada, and New Mexico. The procurement specifically requires specialized LC/MS/MS (QSight 225) platform equipment, associated software, and FDA-cleared reagent kits for screening Lysosomal Storage Disorders, Amino Acids, and Acylcarnitines. The special procurement is limited to Marion County and the City of Salem, with a notice period for potential protests of seven calendar days from the posting date of September 19, 2023, and a response deadline of September 26, 2023.

The procurement is a sole source contract, meaning no competitive bidding process is available due to PerkinElmer being the exclusive manufacturer and worldwide distributor of the required testing kits and equipment. No specific set-aside designations for disadvantaged enterprises are mentioned in the documentation. The total estimated contract value for the amendment period is $15,166,314, which covers instrument leasing, reagent kits, consumables, and software maintenance for five QSight instruments. The existing infrastructure includes the current PerkinElmer Specimen Gate software initially acquired in 2013, which will be enhanced to accommodate four new newborn screening tests. The contract aims to eliminate manual processes, reduce risks and errors, and decrease reporting time for newborn screening results. No alternative vendors are identified, and the justification for the sole source procurement stems from the specialized nature of the equipment and the critical public health services provided by the Newborn Screening Program.